期刊文献+

胃癌中Flt-1、PDGFR、bFGFR的表达与COX-2的相关性 被引量:1

Relationship of Flt-1,PDGFR,bFGFR and COX-2 in gastric cancer
下载PDF
导出
摘要 目的探讨血管内皮生长因子受体-1(Flt-1)、血小板衍生生长因子受体(PDGFR)、碱性成纤维生长因子受体(bFGFR)和环氧合酶-2(COX-2)与胃癌生物学行为的关系以及受体与COX-2的相关性。方法选择80例手术切除的胃癌标本为观察组,40例慢性非萎缩性胃炎组织为对照组,应用免疫组织化学方法检测上述组织中Flt-1、PDGFR、bFGFR及COX-2的蛋白表达情况。结果 Flt-1、PDGFR、bFGFR及COX-2在胃癌患者中的阳性率分别为52.5%、48.8%、50.7%和52.5%。对照组的阳性率分别为7.5%、2.5%、5.0%和0%,差异均有统计学意义(P<0.01),它们的表达与肿瘤的分期、浸润、淋巴及血道转移呈正相关(P<0.05),与肿瘤的大小、分化程度无关(P>0.05)。3种受体与COX-2的表达成正相关(P<0.01)。4种指标均阳性和4种指标均阴性者与淋巴结及远处转移差异有统计学意义(P<0.01)。结论胃癌组织中Flt-1、PDGFR、bFGFR和COX-2的阳性表达可作为胃癌生长、转移及预后的重要判定指标,它们在胃癌的发生、浸润、转移中可能存在相互诱导,相互协同或叠加作用。 【Objective】 To investigate the relationship of vascular growth factor receptor-1(Flt-1),platelet-derived growth factor receptor(PDGFR),basic fibroblast growth factor receptor(bFGFR) and COX-2 to the clinic-pathological of gastric cancer.And to investigate three growth factor receptor relationship with COX-2.【Methods】 Tissue section from 80 gastric cancer(GC),40 chronic non-atrophy gastritis tissue were examined by using immunohistochemistry for the expression of angiogenic factor receptor and COX-2.【Results】 The positivity rates of Flt-1,PDGFR,bFGFR,COX-2 were 52.5%,48.8%,50.7%,and 52.5% respectively,were significantly higher than in patients with chronic non-atrophy gastritis tissue(P〈0.05).The high positive expression of three receptors and COX-2 had significant by positive correlation with stage,regional invasion and lymphatic and blood stream metastasis in GC(P〈0.05).But has no correlation with the size and differentiation degree(P〈0.05).There has significantly correlation among the expression of Flt-1,PDGFR,bFGFR.The incidence rates of metastasis Four index positively expressed and four index negative has relationship with lymphatic and blood stream metastasis(P〈0.01).【Conclusions】 The expression of Flt-1,PDGFR,bFGFR might be significantly correlation with growth,invasion and metastasis of gastric cancer.The four receptors together may play coordination role in angiogenesis,invasion.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第23期2864-2869,共6页 China Journal of Modern Medicine
基金 广西科技厅科研基金(桂科基No:0342010-4)
关键词 胃癌 血管内皮生长因子受体-1(Flt-1) 血小板衍生生长因子受体(PDGFR) 碱性成纤维生长因子受体(bFGFR) 环氧合酶-2(COX-2) gastric neoplasmas vascular growth factor receptor-1(Flt-1) platelet-derived growth factor(PDGF) basic fibroblast growth factor receptor(bFGFR) COX-2
  • 相关文献

参考文献7

二级参考文献40

  • 1Yu Cheng Tang,Yu Li,Guan Xiang Qian Department of Biochemistry, Shanghai Second Medical University, Shanghai 200025, China.Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy[J].World Journal of Gastroenterology,2001,7(1):22-27. 被引量:33
  • 2Wei Xin Niu,Xin Yu Qin,Han Liu,Cheng Pei Wang Surgical Department, Zhongshan Hospital, Fu Dan University Medical Center, Shanghai 200032, China.Clinicopathological analysis of patients with gastric cancer in 1200 cases[J].World Journal of Gastroenterology,2001,7(2):281-284. 被引量:29
  • 3Chang-Tai Xu~1 Lian-Tian Huang~1 Bo-Rong Pan~2 1 Editorial Department,the Journal of Fourth Military Medical University2 Oncology Center,Xijing Hospital,Fourth Military Medical University,169 Changle Xilu,Xi’an 710032,Shaanxi Province,China.Current gene therapy for stomach carcinoma[J].World Journal of Gastroenterology,2001,7(6):752-759. 被引量:16
  • 4赵仲生,姚根有,茹国庆,马杰,阮俊.碱性成纤维细胞生长因子和基质金属蛋白酶-9mRNA表达与胃癌临床病理学及生存期的关系[J].中华外科杂志,2005,43(3):169-173. 被引量:6
  • 5Chen - Guo K, Hong - Yaw C, Chung - Chou J, et al. Role of angiogenisis in hepatitis and hepatcoellular carcinoma[J]. Hepto Gastroenterology, 1999,46:646 - 650
  • 6Kim HR, Yu J, Ustach C. Platelet - derived Growth Factor Signaling and Human Cancer[J] .J Biochem Mol Biol,2003,36(1) :49 - 59
  • 7Vermeulen PB, Van - den - Eynden - GG, Huget - p, et al. Prospective study of intratumor microvessel density, p53 expression and survival in colorectal cancer[J]. Br J Cancer, 1999,79(2) :316 - 322
  • 8Naohiko K, Hiroyuki W, Kazuyuki Y, et al. Immunohistochemical expression of thymidine phosphorylase/platelet - derived endothelial cell growth in squamous cell carcinoma of the esophagus[J]. Hepto Gastroenterology, 1999,46:944-951
  • 9Weidner N, Semple JP, Weleh WR, et al. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma[J]. N Engl J Med, 1991, 324:1-8
  • 10Pallares J, Rojo F, Ifiarte J, et al. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol, 2006,21 : 857-865.

共引文献87

同被引文献18

  • 1DURAI PC, THAPPA DM, KUMARI R, et al. Aging in elderly: chronological versus photoaging[J]. Indian J Dermatol, 2012, 57(5): 343-352.
  • 2BIANCHINI F, MASSI D, MARCONI C, et al. Expression of eyclooxygenase-2 in macrophages associated with cutaneous melanoma at diverent stages of progression[J]. Prostaglandins Oth- er Lipid Mediat, 2007, 83: 320-328.
  • 3CHWIROT BW, KUZBICKI L. Cycleoxygenase-2 (COX-2): first marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours[J]. Melanoma Res, 2007, 17: 139-145.
  • 4RAGHAVENDRA G, SUBBARAO VM, DHIMANT D, et al. Si- multaneous targeting of COX-2 GSH to inhibit melanoma[J]. Mol and AKT using selenocoxib-1- Cancer Ther, 2013, 12(1): 3-15.
  • 5MARYAM S, SHAHRYAR S, SEPIDEH S, et al. Cyclooxyge- nase-2 expression in oral squamous cell carcinoma[J]. Journal of Cancer Research and Therapeutics, 2014, 10(4): 1024-1029.
  • 6JOHANSSON CC, EGYHAZI S, MASUCCI G, et al. Prognostic significance of tumor iNOS and COX-2 in stage malignant cutaneous melanoma[J]. Cancer Immunol Immunother, 2009, 58(7): 1085-1094.
  • 7BECKER MR, SIEGELIN MD, ROMPEL R, et al. COX-2 ex- pression in malignant melanoma: a novel prognostic marker[J]. Melanoma Res, 2009, 19(1): 8-16.
  • 8KUZBICKI L, LANGE D, STRACZYlqSKA-NIEMIEC A, et al. The value of cycleoxygenase-2 expression in differentiating be- tween early melanomas and histopathologically difficult types of benign human skin lesions[J]. Melanoma Research, 2012, 22(t): 70-76.
  • 9YI C, ZHANG Y, YU Z, et al. Melatonin enhances the an- ti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-K B/p300 signaling pathways[j]. PloS One, 2014, 9(7): 1-11.
  • 10RAO DS, GUI D, KOSKI ME, et al. An inverse relation be- tween COX-2 and E-cadherin expression correlates with ag- gressive histologic features in prostate cancer [J]. Appl Immuno- histochem Mol Morphol, 2006, 14: 375-383.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部